Attorney General Todd Rokita today announced a settlement with Glenmark Pharmaceuticals, a generic drug manufacturer that allegedly conspired to inflate prices and limit competition, will bring Indiana $154,000.
“We continue holding Big Pharma accountable when they harm Hoosiers by putting profits over people,” Attorney General Rokita said. “These companies must be made to honor their ethical and legal obligations to consumers.”
If you bought certain generic prescription drugs in the United States between May 1, 2009, and December 31, 2019, you could be eligible for money. To find out, call 1-866-290-0182, email info@AGGenericDrugs.com or visit www.AGGenericDrugs.com.
Indiana is part of a coalition of 48 states and territories entering into a $29.6 million settlement with Glenmark. As part of the settlement agreement, Glenmark has agreed to comply with antitrust laws and implement internal reforms to bring about fair competition.
City of Shelbyville receives federal funding for dual utility study
BRCF puts GIFT IX funding into action to address community health priorities
United Way of Central Indiana launches statewide health plan to strengthen human services nonprofits
Shelbyville Common Council approves stricter ordinance to limit downtown truck traffic
City of Shelbyville to break ground on $35 million market-rate apartment development
Indiana Farm Bureau Insurance announces 2027 summer internship program
Blue River Career Programs honored by Indiana Department of Workforce Development
Four arrests in Decatur County for human trafficking and child solicitation
